Beyond ACE2 downregulation: daphnetin as a multi-target agent for COVID-19 and rheumatic comorbidities

European Journal of Pharmacology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles